Original Investigation

Juvenile granulosa cell ovarian tumor: clinicopathological evaluation of ten patients


  • Alper Karalök
  • Tolga Tasçi
  • Isin Üreyen
  • Osman Türkmen
  • Reyhan Öçalan
  • Gülsah Sahin
  • Taner Turan
  • Gökhan Tulunay

Received Date: 01.11.2014 Accepted Date: 30.12.2014 J Turk Ger Gynecol Assoc 2015;16(1):32-34 PMID: 25788847


We aimed to analyze the clinical characteristics and management of ten patients who were diagnosed with juvenile granulosa cell ovarian tumor (JGCOT).

Material and Methods:

The records of 10 patients diagnosed with JGCOT between April 1995 and January 2014 in the Gynecological Oncology Clinic of our institution were retrospectively evaluated.


The median age of the patients was 21.5 years (range; 13-36). Nine patients had stage IA disease and one had stage IC disease according to the International Federation of Gynecology and Obstetrics (FIGO) criteria. Five patients underwent pelvic and para-aortic lymph node dissection. None of them had lymph node involvement. All but two patients underwent unilateral salpingo-oophorectomy. One of the other two patients had cystectomy and the other had total abdominal hysterectomy and bilateral salpingo-oophorectomy. Three patients had adjuvant therapy after surgery. Two of these patients took chemotherapy and the other took radiotherapy. Four of the five patients who desired pregnancy achieved five term pregnancies. The median follow-up time of the patients was 58 months (range; 3-113). No recurrence was observed in the follow up period.


JGCOT generally occurs during childhood. The primary management of JGCOT is through surgery. The role of adjuvant therapy is controversial. Because survival is long at early stages and most of the patients are young, fertility sparing surgery could be safely suggested to these patients.

Keywords: Juvenile granulosa cell tumor, ovary, adjuvant therapy, fertility sparing surgery